Nouvelle déclaration d'incident
No de la demande: 2013-3567
Numéro de référence du titulaire d'homologation: PROSAR Case#: 1-34063042
Nom du titulaire (nom légal complet, aucune abbréviation): Syngenta Canada Inc.
Adresse: 140 Research Lane, Research Park
Ville: Guelph
État: Ontario
Pays: Canada
Code postal /Zip: N1G4Z3
Incident chez un animal domestique
Pays: UNITED STATES
État: NEBRASKA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. Inconnu
Nom du produit: Fusilade (nonspecific)
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Round Up (unspecific)
Liquide
Oui
Inconnu
Site: Agricultural-Outdoor/Agricole-extérieur
Specify Type: Soybean
Inconnu
Professionnel de la santé
Cow / Vache
Cross bred
1
Homme
0.5
450
lbs
Inconnu
Unknown / Inconnu
Unknown / Inconnu
Système
Persisted until death
Non
Non
Mort
Contact treat.area/Contact surf. traitée
(p.ex. description des symptômes tels que la fréquence et la gravité
1-34063042- The reporter, a veterinarian, indicated an animal may have been exposed to a product containing the herbicide Fluazifop-P-Butyl. The reporter indicated his client, the animal owner, had called the veterinarian the same morning of the initial report to indicate a six month four hundred fifty pound mixed breed steer had escaped its pasture some time the day prior to the initial report. The animal had entered an application area where the product and a non-registrant product had been applied within two days of the exposure. The animal may have consumed soybeans that had been treated. No discreet exposure incident was described. The animal had been found dead the morning of the initial report. The reporter had not examined the animal or the animals remains. The reporter was only able to provide product identification by incomplete name. With the information provided by the reporter it was possible to identify active ingredient of the registrants product but not specific formulation. The non-registrant product was identified by the name Round up. It is probable this second product is a glyphosate based product but the formulation is unknown. The caller was advised the observed outcome would not be consistent with the profile of the active ingredient Fluazifop-P-Butyl. He was encouraged to obtain a necropsy and provide results as they became available. He was also encouraged to contact the registrant of the Round Up product directly to discuss expectations of that product. No further information is available.
Mort